appliedclinicaltrialsonline16d
Potential Updates to FDA’s Protocol Deviations Guidance
In this video interview, Vera Pomerantseva, director of product management, RBQM, eClinical Solutions, talks FDA’s latest protocol deviation guidance and potential changes to the draft. In a recent ...
Nasdaq19d
Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients
The protocol reflects the feedback of these gynecologic oncology experts as well as input from the FDA. The protocol has now also been approved by the Institutional Review Board of the first trial ...
CoinTelegraph29d
KIP Protocol reveals involvement in Javier Milei-endorsed Libra rug pull
KIP Protocol, a Web3 company that builds AI payment infrastructure, disclosed that it was involved in the Libertad project promoted by Argentine President Javier Milei on X, which featured the ...
abc4.com1mon
2 injured in drug-related shooting that led to ‘secure protocols’ in Granite School District
TAYLORSVILLE, Utah (ABC4) — Officials provided more information about an apparent drug-related shooting that led to several ... Original story: Several Granite School District schools put on ‘secure ...
verywellhealth1mon
The Guaifenesin Protocol for Fibromyalgia
When you look online for fibromyalgia treatments, it's common to come across references to guaifenesin, which is the drug in Mucinex. The Guaifenesin Protocol for treating fibromyalgia (FMS) is based ...
BMJ1mon
VITALITY trial: protocol for a randomised controlled trial to establish the role of postnatal vitamin D supplementation in infant immune health
Daily diaries will be used to record compliance with drug dosing, changes to infant feeding ... be performed according to standard guidelines as per previous HealthNuts protocol.20 Eczema: Eczema ...
Santé log1mon
March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, today ...
Nasdaq1mon
Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 AURORA Trial of Descartes-08 in Myasthenia Gravis
FREDERICK, Md., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering ...